412 related articles for article (PubMed ID: 12678793)
1. Cationic lipid vectors for plasmid DNA delivery.
Hirko A; Tang F; Hughes JA
Curr Med Chem; 2003 Jul; 10(14):1185-93. PubMed ID: 12678793
[TBL] [Abstract][Full Text] [Related]
2. Cationic lipids in gene delivery: principles, vector design and therapeutical applications.
Ilies MA; Seitz WA; Balaban AT
Curr Pharm Des; 2002; 8(27):2441-73. PubMed ID: 12369942
[TBL] [Abstract][Full Text] [Related]
3. Progress in cationic lipid-mediated gene transfection: a series of bio-inspired lipids as an example.
Montier T; Benvegnu T; Jaffrès PA; Yaouanc JJ; Lehn P
Curr Gene Ther; 2008 Oct; 8(5):296-312. PubMed ID: 18855628
[TBL] [Abstract][Full Text] [Related]
4. Cationic liposomes for gene delivery: novel cationic lipids and enhancement by proteins and peptides.
Düzgüneş N; De Ilarduya CT; Simões S; Zhdanov RI; Konopka K; Pedroso de Lima MC
Curr Med Chem; 2003 Jul; 10(14):1213-20. PubMed ID: 12678795
[TBL] [Abstract][Full Text] [Related]
5. Gene delivery using ternary lipopolyplexes incorporating branched cationic peptides: the role of Peptide sequence and branching.
Welser K; Campbell F; Kudsiova L; Mohammadi A; Dawson N; Hart SL; Barlow DJ; Hailes HC; Lawrence MJ; Tabor AB
Mol Pharm; 2013 Jan; 10(1):127-41. PubMed ID: 23210981
[TBL] [Abstract][Full Text] [Related]
6. Optimizing cationic and neutral lipids for efficient gene delivery at high serum content.
Chan CL; Ewert KK; Majzoub RN; Hwu YK; Liang KS; Leal C; Safinya CR
J Gene Med; 2014; 16(3-4):84-96. PubMed ID: 24753287
[TBL] [Abstract][Full Text] [Related]
7. The problem with cationic liposome/micelle-based non-viral vector systems for gene therapy.
Miller AD
Curr Med Chem; 2003 Jul; 10(14):1195-211. PubMed ID: 12678794
[TBL] [Abstract][Full Text] [Related]
8. Recent patents in cationic lipid carriers for delivery of nucleic acids.
Koynova R; Tenchov B
Recent Pat DNA Gene Seq; 2011 Apr; 5(1):8-27. PubMed ID: 21288191
[TBL] [Abstract][Full Text] [Related]
9. Plasmid DNA-encapsulating liposomes: effect of a spacer between the cationic head group and hydrophobic moieties of the lipids on gene expression efficiency.
Obata Y; Saito S; Takeda N; Takeoka S
Biochim Biophys Acta; 2009 May; 1788(5):1148-58. PubMed ID: 19249283
[TBL] [Abstract][Full Text] [Related]
10. Novel cationic lipids possessing protonated cyclen and imidazolium salt for gene delivery.
Huang QD; Ou WJ; Chen H; Feng ZH; Wang JY; Zhang J; Zhu W; Yu XQ
Eur J Pharm Biopharm; 2011 Aug; 78(3):326-35. PubMed ID: 21439377
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical parameters of non-viral vectors that govern transfection efficiency.
Barteau B; Chèvre R; Letrou-Bonneval E; Labas R; Lambert O; Pitard B
Curr Gene Ther; 2008 Oct; 8(5):313-23. PubMed ID: 18855629
[TBL] [Abstract][Full Text] [Related]
12. Cationic transfection lipids in gene therapy: successes, set-backs, challenges and promises.
Kumar VV; Singh RS; Chaudhuri A
Curr Med Chem; 2003 Jul; 10(14):1297-306. PubMed ID: 12678801
[TBL] [Abstract][Full Text] [Related]
13. Non-viral vectors based on cationic niosomes and minicircle DNA technology enhance gene delivery efficiency for biomedical applications in retinal disorders.
Gallego I; Villate-Beitia I; Martínez-Navarrete G; Menéndez M; López-Méndez T; Soto-Sánchez C; Zárate J; Puras G; Fernández E; Pedraz JL
Nanomedicine; 2019 Apr; 17():308-318. PubMed ID: 30790710
[TBL] [Abstract][Full Text] [Related]
14. In vivo characteristics of cationic liposomes as delivery vectors for gene therapy.
Audouy SA; de Leij LF; Hoekstra D; Molema G
Pharm Res; 2002 Nov; 19(11):1599-605. PubMed ID: 12458664
[TBL] [Abstract][Full Text] [Related]
15. Current status of non-viral gene therapy for CNS disorders.
Jayant RD; Sosa D; Kaushik A; Atluri V; Vashist A; Tomitaka A; Nair M
Expert Opin Drug Deliv; 2016 Oct; 13(10):1433-45. PubMed ID: 27249310
[TBL] [Abstract][Full Text] [Related]
16. Cationic lipids containing cyclen and ammonium moieties as gene delivery vectors.
Huang QD; Ren J; Ou WJ; Fu Y; Cai MQ; Zhang J; Zhu W; Yu XQ
Chem Biol Drug Des; 2012 Jun; 79(6):879-87. PubMed ID: 22321835
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a novel diolein-based LPDII vector for gene delivery.
Guo W; Gosselin MA; Lee RJ
J Control Release; 2002 Sep; 83(1):121-32. PubMed ID: 12220844
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol derived cationic lipids as potential non-viral gene delivery vectors and their serum compatibility.
Ju J; Huan ML; Wan N; Hou YL; Ma XX; Jia YY; Li C; Zhou SY; Zhang BL
Bioorg Med Chem Lett; 2016 May; 26(10):2401-2407. PubMed ID: 27072908
[TBL] [Abstract][Full Text] [Related]
19. Pyridinium cationic lipids in gene delivery: an in vitro and in vivo comparison of transfection efficiency versus a tetraalkylammonium congener.
Ilies MA; Johnson BH; Makori F; Miller A; Seitz WA; Thompson EB; Balaban AT
Arch Biochem Biophys; 2005 Mar; 435(1):217-26. PubMed ID: 15680924
[TBL] [Abstract][Full Text] [Related]
20. Impact of DNA vector topology on non-viral gene therapeutic safety and efficacy.
Sum CH; Wettig S; Slavcev RA
Curr Gene Ther; 2014; 14(4):309-29. PubMed ID: 25039613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
